Literature DB >> 26999056

Cetuximab as First-line Treatment for Metastatic Colorectal Cancer: Caution With Interpretation of Cost-Effectiveness Results Toward Medical Decision Making.

Mira D Franken1, Miriam Koopman, Martijn G H van Oijen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26999056     DOI： 10.1097/COC.0000000000000253

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN： 0277-3732            Impact factor:   2.339


× No keyword cloud information.
  1 in total

1.  Characterization of 7A7, an anti-mouse EGFR monoclonal antibody proposed to be the mouse equivalent of cetuximab.

Authors:  Xuzhi He; Jazmina L Cruz; Shannon Joseph; Nicola Pett; Hui Yi Chew; Zewen K Tuong; Satomi Okano; Gabrielle Kelly; Margaret Veitch; Fiona Simpson; James W Wells
Journal:  Oncotarget       Date:  2018-01-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.